Human resources and hemp-based supplements: new data and best practices
Hemp and CBD supplements are increasingly becoming a topic of conversation in the workplace…
Between European opinions and clinical applications: new benchmarks for the plant extracts sector
The plant extracts sector is entering a more demanding phase of maturity. Between European scientific opinions,…
Regulatory reforms and practical challenges of derivative products: roadside detection, safety and therapeutic access
Regulatory reforms affecting derivatives, innovative therapies, and safety tools do not concern…
Saliva tests, European regulations and medical access: guidelines for derivative products
Saliva tests are generating increasing interest in Europe because they combine ease of use, non-invasiveness, and…
CBD, legality and roadside testing: buying online safely
Buying CBD online can be convenient, economical, and quick, provided you maintain a real habit…
Herbal infusions and supplements: understanding the new European rules and their practical consequences
The market for herbal teas and supplements remains very dynamic in France and in…
Contents, testing and controls: how the European Union and French frameworks are reshaping access to plant extracts
Plant extracts have long benefited, in the collective imagination, from a simple image: a plant, an extraction, a…
Thresholds, security and access: how Europe is reshaping the framework for the therapeutic and industrial plant sector
In Europe, the sector of plants used for therapeutic and industrial purposes is entering a phase of accelerated clarification
Drug interactions and clinical safety of cannabis extracts: guidelines for prescribers
Cannabis extracts are playing an increasingly important role in clinical discussions, whether in formulations rich in…
When hemp-based solutions challenge workplace well-being policies
For a long time, hemp-based solutions were presented to businesses from the perspective of comfort, of…
